MedTrace Logo

Prospective Cohort Study of the Effect of Bariatric/Metabolic Surgery on Morbid Obesity Patients With Metabolic Syndrome

NCT02271568 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-02-19

No results posted yet for this study

Summary

The purpose of this study is to determine the change in kidney function and blood pressure after gastric bypass versus conventional medical therapy in morbid obesity. The study mainly focus on glomerular filtration rate(GFR) with known relation to the renal function and 24 hours ambulatory blood pressure monitoring after intervention of gastric bypass or medical treatment.

Conditions

Interventions

PROCEDURE

Bariatric surgery

Laparoscopic or Robot R-Y gastric bypass

OTHER

Intensive medical therapy

intensive medical therapy according to published guidelines by ADA and EASD

Sponsors & Collaborators

  • Hanyang University

    lead OTHER

Principal Investigators

  • Tae Kyung Ha, MD, PhD · Hanyang University Seoul Hospital

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-12-31
Completion
2017-12-31

Countries

  • South Korea

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02271568 on ClinicalTrials.gov